Abstract:Background Quantitative susceptibility mapping (QSM) is a quantitative measure based on magnetic resonance imaging sensitive to iron and myelin content. This makes QSM a promising non-invasive tool for multiple sclerosis (MS) in research and clinical practice. Objective We performed a systematic review and meta-analysis on the use of QSM in MS. Methods Our review was prospectively registered on PROSPERO (CRD42022309563). We searched five databases for studies published between inception and 30th April 2023. We identified 83 English peer-reviewed studies that applied QSM images on MS cohorts. Fifty-five included studies had at least one of the following outcome measures: deep grey matter QSM values in MS, either compared to healthy controls (HC) (k = 13) or correlated with the score on the Expanded Disability Status Scale (EDSS) (k = 7), QSM lesion characteristics (k = 22) and their clinical correlates (k = 17), longitudinal correlates (k = 11), histological correlates (k = 7), or correlates with other imaging techniques (k = 12). Two meta-analyses on deep grey matter (DGM) susceptibility data were performed, while the remaining findings could only be analyzed descriptively. Results After outlier removal, meta-analyses demonstrated a significant increase in the basal ganglia susceptibility (QSM values) in MS compared to HC, caudate (k = 9, standardized mean difference (SDM) = 0.54, 95 % CI = 0.39–0.70, I 2 = 46 %), putamen (k = 9, SDM = 0.38, 95 % CI = 0.19–0.57, I 2 = 59 %), and globus pallidus (k = 9, SDM = 0.48, 95 % CI = 0.28–0.67, I 2 = 60 %), whereas thalamic QSM values exhibited a significant reduction (k = 12, SDM = −0.39, 95 % CI = −0.66–−0.12, I 2 = 84 %); these susceptibility differences in MS were independent of age. Further, putamen QSM values positively correlated with EDSS (k = 4, r = 0.36, 95 % CI = 0.16–0.53, I 2 = 0 %). Regarding rim lesions, four out of seven studies, representing 73 % of all patients, reported rim lesions to be associated with more severe disability. Moreover, lesion development from initial detection to the inactive stage is paralleled by increasing, plateauing (after about two years), and gradually decreasing QSM values, respectively. Only one longitudinal study provided clinical outcome measures and found no association. Histological data suggest iron content to be the primary source of QSM values in DGM and at the edges of rim lesions; further, when also considering data from myelin water imaging, the decrease of myelin is likely to drive the increase of QSM values within WM lesions Conclusions We could provide meta-analytic evidence for DGM susceptibility changes in MS compared to HC; basal ganglia susceptibility is increased and, in the putamen, associated with disability, while thalamic susceptibility is decreased. Beyond these findings, further investigations are necessary to establish the role of QSM in MS for research or even clinical routine.

Quantitative Susceptibility Mapping-Derived Radiomic Features in Discriminating Multiple Sclerosis From Neuromyelitis Optica Spectrum Disorder

Joint Radiomics and Spatial Distribution Model for MRI-based Discrimination of Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin-Oligodendrocyte-glycoprotein-igg-associated Disorder.

Quantitative radiomic biomarkers for discrimination between neuromyelitis optica spectrum disorder and multiple sclerosis

An Automated Hybrid Approach Via Deep Learning and Radiomics Focused on the Midbrain and Substantia Nigra to Detect Early-Stage Parkinson’s Disease

Multi-parametric MRI Phenotype with Trustworthy Machine Learning for Differentiating CNS Demyelinating Diseases

MoG-QSM: Model-based Generative Adversarial Deep Learning Network for Quantitative Susceptibility Mapping.

Radiomics Models Based on Cortical Damages for Identification of Multiple Sclerosis with Cognitive Impairment

Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using a deep learning model

Multiparametric MRI dataset for susceptibility-based radiomic feature extraction and analysis

Multi-lesion radiomics model for discrimination of relapsing-remitting multiple sclerosis and neuropsychiatric systemic lupus erythematosus

A multicenter study of brain T 2WI lesions radiomics machine learning models distinguishing multiple sclerosis and neuromyelitis optica spectrum disorder

Independent and Reproducible Hippocampal Radiomics Biomarkers for Multisite Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders.

Discriminating Minimal Residual Disease Status in Multiple Myeloma Based on MRI: Utility of Radiomics and Comparison of Machine-Learning Methods.

MoDL-QSM: Model-based Deep Learning for Quantitative Susceptibility Mapping

Prediction of unenhanced lesion evolution in multiple sclerosis using radiomics-based models: a machine learning approach

A Radiomic "Warning Sign" of Progression on Brain MRI in Individuals with MS

Radiomics derived from T2-FLAIR: the value of 2- and 3-classification tasks for different lesions in multiple sclerosis

Radiomics-Based Machine Learning in Differentiation Between Primary Central Nervous System Lymphoma And Solitary Brain Metastasis

Differentiating multiple sclerosis from non-specific white matter changes using a convolutional neural network image classification model

Machine Learning-Based Radiomics to Differentiate Immune-Mediated Necrotizing Myopathy from Limb-Girdle Muscular Dystrophy R2 Using MRI.

Quantitative susceptibility mapping in multiple sclerosis: A systematic review and meta-analysis